Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emily Jean Aller
Observed names:
Emily Aller,
Emily J. Aller
Institutions:
The University of Texas at San Antonio Health Science Center,
The University of Texas at San Antonio
Observed institutions:
The University of Texas at San Antonio Health Science Center,
The University of Texas at San Antonio
ORCID:
0009-0002-0612-8200
Observed ORCID:
0009-0002-0612-8200
OpenAlex ID:
A5093482427
Significance of Midkine Signaling in Women’s Cancers: Novel Biomarker and Therapeutic Target
2025
·
Emily J. Aller
, Hareesh B. Nair
, et al.
·
International Journal of Molecular Sciences
·
21
PDF
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling
2023
·
Nicole Spencer
, Alondra Lee Rodriguez Sanchez
, et al.
·
International Journal of Molecular Sciences
·
16
PDF
Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis
2025
·
Bianca Romo
, Zenaida Fuentes
, et al.
·
Cancers
·
2
Abstract 5679: LIFR inhibition with EC359 triggers ferroptosis to overcome chemoresistance in endometrial cancer.
2026
·
Emily Jean Aller
, Baskaran Subramani
, et al.
·
Cancer Research
454 A novel MDK targeted therapy for the treatment of endometrial cancer
2026
·
Emily Aller
, Alondra L. Rodriguez Sanchez
, et al.
·
Journal of Clinical and Translational Science
PDF
Abstract 1630: Targeting the LIF/LIFR axis reduces the progression of inflammatory breast cancer by promoting ferroptosis
2025
·
Bianca A. Romo
, Zenaida Fuentes
, et al.
·
Cancer Research
Abstract 5989: Investigating the potential of EC359 in inducing ferroptosis for the treatment of type I and type II endometrial cancers
2025
·
Emily J. Aller
, Xue Yang
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
39
H-index:
2
I10-index:
2
Year
Topic
Type